Lactic acidosis after treatment with linezolid

Infection

Volumn 35, Issue 4, 2007, Pages 278-281

  Wiener, M ^a,b   Guo, Y ^b   Patel, G ^c   Fries, B C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; METOPROLOL; PANTOPRAZOLE; PIPERACILLIN PLUS TAZOBACTAM; THIAMINE; WARFARIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; ATELECTASIS; BACTEREMIA; BRONCHIECTASIS; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; DEEP VEIN THROMBOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS FAECIUM; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL INFECTION; HUMAN; HYPERLACTATEMIA; IMPLANTATION; LACTIC ACIDOSIS; MITRAL VALVE REPLACEMENT; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TACHYPNEA; THORAX PAIN; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACETAMIDES; ACIDOSIS, LACTIC; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; CARDIAC SURGICAL PROCEDURES; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; OXAZOLIDINONES; VANCOMYCIN RESISTANCE;

EID: 34547666898     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-6302-x     Document Type: Review

References (18)

1. Moellering RC: Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 2003; 138: 135-142.
2. Zyvox [package insert]: Pharmacia & Upjohn, New York 2005.
3. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Bolfer AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch J, Takahashi M, Taubert KA: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and anesthesia, American Heart Association: endorsed by the infectious diseases society of America. Circulation 2005; 111: 394-434.
4. Bishop E, Melvani S, Howden BP, Charles PG, Grayson ML: Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients. Antimicrob Agents Chemother 2006; 50: 1599-1602.
5. McKee EE, Ferguson M, Bentley AT, Marks TA: Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 2006; 50: 2042-2049.
6. Soriano A, Miro O, Mensa J: Mitochondrial toxicity associated with linezolid. N Engl J Med 2005; 353: 2305-2306.
7. DeVriese AS, VanCoster R, Smet J, Seneca S, Lovering A, VanHaute LL, Vanopdenbosch LJ, Martin JJ, Ceuterick-deGroote C, Vandecasteele S, Boelaert JR: Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006; 42: 1111-1117.
8. Duewelhenke N, Krut O, Eysel P: Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines. Antimicrob Agents Chemother 2007; 51: 54-63.
9. Dawson MA, Davis A, Elliott P, Cole-Sinclaire M: Linezolidinduced dyserythropoiesis: chloramphenicol toxicity revisited. Intern Med J 2005; 35: 626-628.
10. Palenzuela L, Hahn NM, Nelson RP, Arno JN, Schobert C, Bethel R, Ostrowski LA, Sharma MR, Datta PP, Agrawal RK, Schwartz JE, Hirano M: Does linezolid cause lactic acidosis by inhibiting mitochondrial protein synthesis? Clin Infect Dis 2005; 40: e113-e116.
11. Cote HCF, Brumme ZL, Craib KJP, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O'Shaughnessy MV, Montaner JSG: Changes in mitchondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002; 346: 811-820.
12. Arenas-Pinto A, Grant AD, Edwards S, Weller IV: Lactic acidosis in HIV infected patients: a systematic review of published cases. Sex Transm Infect 2003; 79: 340-344.
13. Bernard L, Stern R, Lew D, Hoffmeyer P: Serotonin syndrome after concomitant treatment with linezolid and citalopram. Clin Infect Dis 2003; 36: 1197.
14. Pea F, Scudeller L, Lugano M, Baccarani U, Pavan F, Tavio M, Furlanut M, Della Rocca G, Bresadola F, Viale P: Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient. Clin Infect Dis 2006; 42: 434-435.
15. Kopterides P, Papadomichelakis E, Armaganidis A: Linezolid use associated with lactic acidosis. Scand J Infect Dis 2005; 37: 153-154.
16. Apodaca AA, Rakita RM: Linezolid-induced lactic acidosis. N Engl J Med 2003; 348: 86-87.
17. Klein M, Weksler N, Gurman GM: Fatal metabolic acidosis caused by thiamine deficiency. J Emerg Med 2004; 26: 301-303.
18. Spellberg B, Yoo T, Bayer AS: Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother 2004; 54: 832-835.